A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
Clinical trial NCT03316794 · TERMINATED
Trial details
- NCT number
- NCT03316794
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-04
- Primary completion
- 2018-10-05
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.